Evidence map›Paper›PMID 40155787›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2025

Drug susceptibility testing for TB using the Xpert MTB/XDR assay on stool specimens.

W Khumalo, N Maphalala, D Mulengwa, M Ziyane, D B Sibandze, S Niemann, V Dreyer, A Seeger, M Madison, T Ness and 6 more

Abstract read
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

W KhumaloBaylor College of Medicine Children's Foundation-Eswatini, Mbabane, Eswatini.
N MaphalalaBaylor College of Medicine Children's Foundation-Eswatini, Mbabane, Eswatini.
D MulengwaBaylor College of Medicine Children's Foundation-Eswatini, Mbabane, Eswatini.
M ZiyaneBaylor College of Medicine Children's Foundation-Eswatini, Mbabane, Eswatini;, National Tuberculosis Reference Laboratory, Eswatini Health Laboratory Services, Ministry of Health, Mbabane, Eswatini.
D B SibandzeNational Tuberculosis Reference Laboratory, Eswatini Health Laboratory Services, Ministry of Health, Mbabane, Eswatini;, Amsterdam Institute for Global Health and Development, Department of Global Health, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
S NiemannResearch Center Borstel - Leibniz Lung Center, Molecular and Experimental Mycobacteriology, Borstel, Germany;, German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany.
V DreyerResearch Center Borstel - Leibniz Lung Center, Molecular and Experimental Mycobacteriology, Borstel, Germany;, German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany.
A SeegerBaylor College of Medicine, Department of Pediatrics, Division of Global Health, Houston, TX, United States.
M MadisonBaylor College of Medicine Children's Foundation-Eswatini, Mbabane, Eswatini;, Baylor College of Medicine, Department of Pediatrics, Division of Global Health, Houston, TX, United States.
T NessBaylor College of Medicine, Department of Pediatrics, Division of Global Health, Houston, TX, United States.
T JeleEswatini National Tuberculosis Control Program, Ministry of Health, Manzini, Eswatini.
A L Garcia-BasteiroBarcelona Institute for Global Health, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain;, Centro de Investigação em Saude de Manhiça (CISM), Maputo, Mozambique;, Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Barcelona, Spain.
G MaphalalaEswatini Health Laboratory Services, Ministry of Health, Mbabane, Eswatini.
A R DiNardoBaylor College of Medicine, Department of Pediatrics, Division of Global Health, Houston, TX, United States.
A M MandalakasGerman Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany;, Baylor College of Medicine, Department of Pediatrics, Division of Global Health, Houston, TX, United States;, University of Texas School of Public Health, Department of Epidemiology, Human Genetics, and Environmental Sciences, Houston, TX, USA; on behalf of the Stool4TB Global Partnership.
A KayBaylor College of Medicine Children's Foundation-Eswatini, Mbabane, Eswatini;, Baylor College of Medicine, Department of Pediatrics, Division of Global Health, Houston, TX, United States.

Funding

Post-TB epigenetic scars' impact on long-term inflammation, immunity and mortalityR01AI170774 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI Andrew R DiNardo · 2023 to 2026
$2.9M
Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment MonitoringR01AI137527 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI MANDALAKAS, ANNA M · 2019 to 2022
$2.7M
Wastewater surveillance to enhance the public health response to HIV and TB in EswatiniDP1HD115427 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI Alexander William Kay · 2024 to 2026
$1.7M
Developing Clinical Prediction Tools to Define Strategies for Differentiated Service Delivery in Children and Adolescents Living with HIV in sub-Saharan Africa.K01TW011482 · FIC · BAYLOR COLLEGE OF MEDICINE · PI KAY, ALEXANDER WILLIAM · 2020 to 2024
$749k
FIC NIH HHS K01 TW011482NIAID NIH HHS R01 AI137527NIAID NIH HHS R01 AI170774NICHD NIH HHS DP1 HD115427
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40155787
PMCPMC12129363

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.